Showing results (121-130 of 194) with videos related to

Sort By:
Pageof 20
Arthritis Care & Research|April 21, 2015
Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune DiseasesThomas E Lloyd, Lisa Christopher-Stine, Iago Pinal-Fernandez, et al.
The Journal of Rheumatology|August 1, 2024
The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis SymptomsLisa Christopher-Stine, Anna Ciesluk, Hector Chinoy, et al.
Rheumatology (Oxford, England)|May 25, 2024
Extracorporeal membrane oxygenation for acute lung injury in idiopathic inflammatory myopathies-a potential lifesaving interventionBoyang Zheng, Ellen Eline, Lillian Xu, et al.
Rheumatology (Oxford, England)|September 19, 2025
N-formyl methionine peptide-driven neutrophil activation in idiopathic inflammatory myopathiesJorge A Gonzalez-Chapa, Begum Horuluoglu, Antonella Notarnicola, et al.
Chest|February 20, 2009
Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literatureMeena Kalluri, Steven A Sahn, Chester V Oddis, et al.
Clinical and Experimental Rheumatology|September 8, 2020
Accumulation of autophagosome cargo protein p62 is common in idiopathic inflammatory myopathiesJose C Milisenda, Iago Pinal-Fernandez, Thomas E Lloyd, et al.
ACR Open Rheumatology|March 28, 2021
A North American Cohort of Anti-SAE Dermatomyositis: Clinical Phenotype, Testing, and Review of CasesJemima Albayda, Christopher Mecoli, Livia Casciola-Rosen, et al.
Neurology|March 3, 2019
Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodiesMaria Casal-Dominguez, Iago Pinal-Fernandez, Andrea M Corse, et al.
Chest|June 26, 2019
Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung DiseaseJulio A Huapaya, Leann Silhan, Iago Pinal-Fernandez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA VaccinationCaoilfhionn M Connolly, Jake A Ruddy, Brian J Boyarsky, et al.
Pageof 20